Separate quantification of anastrozole and letrozole by a novel stability‐indicating ultra‐fast LC method

[1]  B. Jiang,et al.  Development and validation of a rapid LC-MS/MS method to quantify letrozole in human plasma and its application to therapeutic drug monitoring. , 2016, Biomedical chromatography : BMC.

[2]  M. Fouad,et al.  Preparation and characterization of two new forced degradation products of letrozole and development of a stability-indicating RP-LC method for its determination. , 2015, Pakistan journal of pharmaceutical sciences.

[3]  R. Yadav,et al.  METHOD VALIDATION AND QUANTITATIVE DETERMINATION OF ANASTROZOLE IN HUMAN PLASMA BY A LCMS / MS , 2014 .

[4]  G. Castañeda,et al.  Rapid determination of letrozole, citalopram and their metabolites by high performance liquid chromatography-fluorescence detection in urine: Method validation and application to real samples. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  G. Devalarao,et al.  A novel validated RP-HPLC method for the determination of anastrozole in bulk and pharmaceutical tablet dosage forms , 2013 .

[6]  P. García,et al.  Development and validation of a simple and sensitive high performance liquid chromatographic method for the simultaneous determination of anastrozole, bicalutamide, tamoxifen, and their synthetic impurities. , 2012, Talanta.

[7]  B. Panda,et al.  Development of a High-Performance Liquid Chromatographic Method for Determination of Letrozole in Wistar Rat Serum and its Application in Pharmacokinetic Studies , 2012, Scientia pharmaceutica.

[8]  H. Brauch,et al.  Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS , 2012, Analytical and Bioanalytical Chemistry.

[9]  M. M. Annapurna,et al.  Stability-indicating liquid chromatographic method for the determination of Letrozole in pharmaceutical formulations , 2012, Journal of pharmaceutical analysis.

[10]  H. Lee,et al.  Hydrophilic interaction chromatography-electrospray ionization tandem mass spectrometric analysis of anastrozole in human plasma and its application to a pharmacokinetic study. , 2012, Biomedical chromatography : BMC.

[11]  R. Yadav,et al.  Development and Validation of Simultaneous Detrmination of Anastrozole and Temozolomide in Pharmaceutical Dosage Forms , 2012 .

[12]  H. Ranganathan,et al.  FORCED DEGRADATION STUDY OF LETROZOLE-A VALIDATED STABILITY INDICATING HPLC ASSAY FOR BULK AND TABLET DOSAGE FORM , 2012 .

[13]  Z. Xiong,et al.  An ultraperformance liquid chromatography-tandem mass spectrometry method for determination of anastrozole in human plasma and its application to a pharmacokinetic study. , 2011, Biomedical chromatography : BMC.

[14]  B. Holzner,et al.  Abstract P5-11-09: A Validated Analytical Method for Monitoring the Plasma Levels of Tamoxifen, Anastrozole and Letrozole in Patients Undergoing Endocrine Therapy , 2010 .

[15]  H. Oberacher,et al.  Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study , 2010, Analytical and bioanalytical chemistry.

[16]  P. S. Devi,et al.  Development and Validation of a Planar Chromatographic Method with Reflectance Scanning Densitometry for Quantitative Analysis of Anastrozole in the Bulk Material and in Tablet Formulations , 2010, JPC – Journal of Planar Chromatography – Modern TLC.

[17]  D. SathisKumar,et al.  Development and validation of spectrophotometric method for estimation of anastrozole bulk and pharmaceutical dosage formulation , 2010 .

[18]  B. Nagaraju,et al.  LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets. , 2009, Journal of pharmaceutical and biomedical analysis.

[19]  A. M. Salcedo,et al.  Rapid quantitative analysis of letrozole, fluoxetine and their metabolites in biological and environmental samples by MEKC , 2009, Electrophoresis.

[20]  S. K. Ghosal,et al.  Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles. , 2009, Acta poloniae pharmaceutica.

[21]  Y. L. Loukas,et al.  Development and validation of an improved high-throughput method for the determination of anastrozole in human plasma by LC-MS/MS and atmospheric pressure chemical ionization. , 2008, Journal of pharmaceutical and biomedical analysis.

[22]  A. M. Salcedo,et al.  Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine. , 2008, Journal of chromatography. A.

[23]  S. Hiriyanna,et al.  Isolation and characterization of process related impurities in anastrozole active pharmaceutical ingredient , 2008 .

[24]  A. Zarghi,et al.  HPLC Determination of Letrozole in Plasma Using Fluorescence Detection: Application to Pharmacokinetic Studies , 2007 .

[25]  M. Suryanarayana,et al.  A Stress Stability Behavior and Development of an LC Assay Method for Anastrozole , 2007 .

[26]  S. K. Ghosal,et al.  Development and validation of a spectrophotometric method for estimation of letrozole in bulk and pharmaceutical formulation. , 2007, Die Pharmazie.

[27]  G. De Nucci,et al.  Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  Won Lee,et al.  Validation and application of a screening method for β2‐agonists, anti‐estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry , 2007 .

[29]  F. Botrè,et al.  A fast liquid chromatographic/mass spectrometric screening method for the simultaneous detection of synthetic glucocorticoids, some stimulants, anti-oestrogen drugs and synthetic anabolic steroids. , 2006, Rapid communications in mass spectrometry : RCM.

[30]  M. Thevis,et al.  Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[31]  M. Thevis,et al.  Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[32]  D. Cameron,et al.  Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast Cancer , 1998, Breast Cancer Research and Treatment.

[33]  A. M. Contento,et al.  Determination of drugs used in advanced breast cancer by capillary gas chromatography of pharmaceutical formulations , 2003 .

[34]  M. J. Bock,et al.  Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-63Ni electron capture detection. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[35]  A. Sioufi,et al.  High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection. , 1996, Journal of chromatography. B, Biomedical applications.

[36]  B. Hillner,et al.  The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.